Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Villa

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|August 3, 2022
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2021
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative studySalvatore Stefano Sciarrone, Alberto Ferrarese, Debora Bizzaro, et al.
Blood Advances|February 9, 2021
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19Erica Villa, Rosina Critelli, Simone Lasagni, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Hepatology (Baltimore, Md.)|April 1, 2018
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting AntiviralsFrancesca Faillaci, Luca Marzi, Rosina Critelli, et al.
Ebiomedicine|December 31, 2018
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancerImanol Zubiete-Franco, Juan L García-Rodríguez, Fernando Lopitz-Otsoa, et al.
Cell Death & Disease|September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosisDavid Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Nature Communications|December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injuryLucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Recenti Progressi in Medicina|May 22, 2015
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]Salvatore D'Angelo, Domenico Germano, Teresa Zolfino, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|August 3, 2022
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2021
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative studySalvatore Stefano Sciarrone, Alberto Ferrarese, Debora Bizzaro, et al.
Blood Advances|February 9, 2021
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19Erica Villa, Rosina Critelli, Simone Lasagni, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Hepatology (Baltimore, Md.)|April 1, 2018
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting AntiviralsFrancesca Faillaci, Luca Marzi, Rosina Critelli, et al.
Ebiomedicine|December 31, 2018
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancerImanol Zubiete-Franco, Juan L García-Rodríguez, Fernando Lopitz-Otsoa, et al.
Cell Death & Disease|September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosisDavid Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Use of albumin infusion for cirrhosis-related complications: An international position statementZhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, et al.
Nature Communications|December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injuryLucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Recenti Progressi in Medicina|May 22, 2015
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]Salvatore D'Angelo, Domenico Germano, Teresa Zolfino, et al.
Pageof 15